Context.—Both atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) have
traditionally been considered to be risk factors for the development of invasive carcinoma …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

We evaluated the efficacy of using standard radiologic and histologic criteria to guide the
follow‐up of patients with lobular carcinoma in situ (LCIS), lobular neoplasia (LN), or atypical …

PURPOSE: To retrospectively determine frequency of invasive cancer or ductal carcinoma in
situ (DCIS) at excisional biopsy in women with atypical lobular hyperplasia (ALH) or lobular …

Core needle biopsy is the preferred technique for evaluating breast masses and abnormal
mammographic findings. The frequency of detection of noninvasive lobular lesions by core …

Standardized recommendations for the management of lobular neoplasia in core biopsy
specimens are not established. The aim of our study was to define morphologic features of …

OBJECTIVE. The objective of our study was to show the importance of surgical excision after
the diagnosis of lobular carcinoma in situ (LCIS) based on needle core biopsy. MATERIALS …

The question of whether excisional biopsy is required following a diagnosis of atypical
lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS) at core-needle biopsy is both …

Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

There are no consensus guidelines for the management of lobular neoplasia diagnosed on
core biopsy as the highest risk factor for cancer. This study aimed to assess the risk of …